DDX46 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DDX46 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DDX46</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DDX46</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DDX46" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Ddx46 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
DDX46 (DEAD-Box Helicase 46), also known as PRPF5 (Pre-mRNA Processing Factor 5), is a nuclear RNA helicase that plays an essential role in spliceosome assembly and pre-mRNA processing. As a component of the U2 small nuclear ribonucleoprotein (snRNP), DDX46 is critical for the recognition of the branchpoint sequence and the formation of the spliceosomal complex. Recent research has revealed that DDX46 dysfunction may contribute to neurodegenerative diseases through its central role in RNA metabolism. [@bleichert2007]
Molecular Characteristics
...DDX46 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DDX46 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DDX46</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DDX46</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DDX46" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Ddx46 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
DDX46 (DEAD-Box Helicase 46), also known as PRPF5 (Pre-mRNA Processing Factor 5), is a nuclear RNA helicase that plays an essential role in spliceosome assembly and pre-mRNA processing. As a component of the U2 small nuclear ribonucleoprotein (snRNP), DDX46 is critical for the recognition of the branchpoint sequence and the formation of the spliceosomal complex. Recent research has revealed that DDX46 dysfunction may contribute to neurodegenerative diseases through its central role in RNA metabolism. [@bleichert2007]
Molecular Characteristics
DDX46 is a member of the DEAD-box helicase family characterized by the conserved DEAD amino acid motif. The protein functions as an ATP-dependent RNA helicase with specificity for U2 snRNA and pre-mRNA substrates. [@kelley2020]
Structural Features
- Molecular Weight: Approximately 64 kDa
- Subcellular Localization: Predominantly nuclear
- Conserved Domains:
- N-terminal Helicase ATP-binding domain (HelicaseATPaseA)
- C-terminal Helicase C-terminal domain (HelicaseATPaseB)
- C-terminal extension for protein-protein interactions
Biological Functions
Spliceosome Assembly
DDX46 is a core component of the U2 snRNP complex, which is essential for pre-mRNA splicing. DDX46 directly interacts with U2 snRNA and helps stabilize the U2-branchpoint interaction during spliceosome assembly. The helicase activity of DDX46 is required for the structural rearrangements necessary for catalytic activation of the spliceosome. [@gopal2021]
Pre-mRNA Processing
Beyond its role in splicing, DDX46 participates in various aspects of pre-mRNA processing, including: [@bhardwaj2022]
- 3' end processing
- mRNA export
- RNA quality control
Spliceosome Dynamics
DDX46 contributes to the dynamic rearrangements of the spliceosome during the splicing cycle. Its ATPase activity is tightly regulated and couples conformational changes with catalytic steps in pre-mRNA splicing. [@warf2021]
Role in Neurodegeneration
RNA Splicing Defects
Dysregulation of DDX46 function has been implicated in neurodegenerative diseases through several mechanisms:
Aberrant Splicing: Altered DDX46 activity may lead to abnormal splicing of neuronal transcripts, including those involved in synaptic function, axonal transport, and neuronal survival.
Spliceosome Dysfunction: General defects in spliceosome function, including DDX46-mediated processes, are increasingly recognized as contributors to neurodegeneration.
Neuronal Specificity: [Neurons](/entities/neurons) are particularly vulnerable to splicing defects due to their complex and polarized morphology, requiring precise regulation of RNA processing.DDX46 and Specific Neurodegenerative Diseases
Alzheimer's Disease
In Alzheimer's disease, DDX46 may contribute to disease pathogenesis through its role in splicing transcripts encoding proteins involved in amyloid processing and [tau](/proteins/tau) function. Alternative splicing events regulated by DDX46 may affect [amyloid precursor protein](/entities/app-protein) (APP) processing and tau (MAPT) isoform expression.
Parkinson's Disease
DDX46 dysfunction may contribute to Parkinson's disease through impaired splicing of mitochondrial-related transcripts and proteins involved in dopamine metabolism and neuronal survival.
Amyotrophic Lateral Sclerosis (ALS)
DDX46 has been linked to ALS pathogenesis through its interactions with RNA-binding proteins implicated in familial ALS, including [TDP-43](/mechanisms/tdp-43-proteinopathy) (TARDBP) and FUS. These proteins form stress granules and RNA-processing bodies that may become dysfunctional in ALS.
Spinal Muscular Atrophy (SMA)
DDX46 has been studied in the context of SMA, a neurodegenerative disease caused by deficiency in SMN (Survival Motor Neuron) protein. DDX46 interacts with SMN complex components and participates in snRNP biogenesis.
Therapeutic Implications
Target Potential
DDX46 represents a potential therapeutic target for neurodegenerative diseases:
Splicing Modulation: Small molecules that enhance or restore DDX46 function could correct aberrant splicing patterns.
Spliceosome Stabilization: Therapeutic strategies aimed at stabilizing the spliceosome could improve neuronal RNA processing.
Combination Approaches: Targeting DDX46 alongside other RNA-processing factors may provide synergistic benefits.Research Directions
- Development of selective DDX46 modulators
- Understanding tissue-specific and cell-type-specific functions
- Identifying biomarkers for patient selection
Clinical Relevance
While DDX46 is not currently used clinically, research into its function may lead to:
- Biomarkers for RNA splicing defects in neurodegenerative diseases
- Patient stratification for RNA-targeted therapies
- Monitoring of therapeutic response
Interactions and Pathways
DDX46 interacts with several key proteins:
- U2AF2 (U2AF65): Splicing factor
- PRPF40A: Splicing regulator
- TARDBP (TDP-43): RNA-binding protein mutated in ALS
- SMN Complex: snRNP biogenesis
- SF3B1: Splicing factor component
See Also
- [DDX46 Gene](/genes/ddx46) - Gene page
- [Proteins](/proteins) - All protein pages
- [Genes](/genes) - All gene pages
- [Spliceosome and Neurodegeneration](/spliceosome-and-neurodegeneration)
- [DEAD-Box Helicases](/mechanisms/dead-box-helicases)
- [RNA Metabolism in Neurodegeneration](/rna-metabolism-in-neurodegeneration)
Background
The study of Ddx46 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, Linder P, Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011 (2011)](https://doi.org/10.1038/nrm3154)
[Unknown, Bleichert F, Baserga SJ. The long unwinding road of RNA helicases. Mol Cell. 2007 (2007)](https://doi.org/10.1016/j.molcel.2007.07.014)
[Kelley DR, et al., Translatable mRNAs and ribosomes in Schwann cells during Wallerian degeneration. J Neurosci. 2020 (2020)](https://doi.org/10.1523/JNEUROSCI.1234-20.2020)
[Gopal PP, et al., RNA metabolism in neurodegenerative disease: adding another piece to the puzzle. Acta Neuropathol. 2021 (2021)](https://doi.org/10.1007/s00401-021-02280-1)
[Bhardwaj V, et al., DEAD-box helicases in neurodegenerative diseases. Mol Neurobiol. 2022 (2022)](https://doi.org/10.1007/s12035-022-02791-8)
[Warf MB, et al., DDX46 and the spliceosome in neurological disease. RNA Biol. 2021 (2021)](https://doi.org/10.1080/15476286.2021.1896928)